Title: Flibanserin: First Global Approval.
Journal: Drugs 20151001
Title: Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder.
Journal: CNS spectrums 20150201
Title: The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20121101
Title: An update on the pharmacological management of female sexual dysfunction.
Journal: Expert opinion on pharmacotherapy 20121001
Title: Population pharmacokinetic/pharmacodynamic model for the sedative effects of flibanserin in healthy volunteers.
Journal: Pharmaceutical research 20120601
Title: Resurgence of interest in sexual dysfunction?
Journal: BJU international 20120601
Title: Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Journal: The journal of sexual medicine 20120401
Title: Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
Journal: The journal of sexual medicine 20120301
Title: Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality.
Journal: The journal of sexual medicine 20120301
Title: Isolation and structural elucidation of flibanserin as an adulterant in a health supplement used for female sexual performance enhancement.
Journal: Journal of pharmaceutical and biomedical analysis 20120105
Title: Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20111201
Title: Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
Journal: The journal of sexual medicine 20111201
Title: Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
Journal: The journal of sexual medicine 20111101
Title: [Depressive disorder, treatment and sexual dysfunction--part II].
Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20111001
Title: Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
Journal: The journal of sexual medicine 20110501
Title: Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder.
Journal: The journal of sexual medicine 20110101
Title: Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness.
Journal: Molecular brain 20110101
Title: Pharmacogenetics of antidepressants.
Journal: Frontiers in pharmacology 20110101
Title: Consultation corner. The latest on female sexual health.
Journal: The Johns Hopkins medical letter health after 50 20101101
Title: [The abandonment of the development of flibanserin].
Journal: Revue medicale suisse 20101027
Title: Boehringer Ingelheim withdraws libido drug for women.
Journal: BMJ (Clinical research ed.) 20101012
Title: Do drugs have a role in turning indifference into passion?
Journal: BMJ (Clinical research ed.) 20101005
Title: Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder.
Journal: The journal of sexual medicine 20101001
Title: [When women complain about lacking libido. The problem with the desire].
Journal: MMW Fortschritte der Medizin 20100902
Title: Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100901
Title: Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
Journal: Women's health (London, England) 20100901
Title: Dysfunctional women remain unsexed.
Journal: BJU international 20100801
Title: [Normality of the female libido? (2)].
Journal: Revue medicale suisse 20100714
Title: Drug for low sexual desire carries significant harms, FDA advisers find.
Journal: BMJ (Clinical research ed.) 20100707
Title: [Normality of the female libido (1)].
Journal: Revue medicale suisse 20100630
Title: Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20100601
Title: FDA advisers to assess drug for low sexual desire in women.
Journal: BMJ (Clinical research ed.) 20100525
Title: Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study.
Journal: The journal of sexual medicine 20100501
Title: Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test.
Journal: Pharmacology, biochemistry, and behavior 20100501
Title: Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.
Journal: Frontiers in neuroscience 20100101
Title: Management of hypoactive sexual desire disorder in women: current and emerging therapies.
Journal: International journal of women's health 20100101
Title: A new strategy for antidepressant prescription.
Journal: Frontiers in neuroscience 20100101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090501
Title: Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells.
Journal: The international journal of neuropsychopharmacology 20080501
Title: High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity.
Journal: Journal of medicinal chemistry 20071004
Title: Redistribution of the water channel protein aquaporin-4 and the K+ channel protein Kir4.1 differs in low- and high-grade human brain tumors.
Journal: Acta neuropathologica 20050401
Title: Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.
Journal: The international journal of neuropsychopharmacology 20041201
Title: Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine.
Journal: The Journal of pharmacy and pharmacology 20040101
Title: Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.
Journal: British journal of pharmacology 20030801
Title: Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain.
Journal: The international journal of neuropsychopharmacology 20020601
Title: Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media.
Journal: Pharmaceutical research 20020301
Title: Pharmacology of flibanserin.
Journal: CNS drug reviews 20020101
Title: Mechanism of action of flibanserin in the learned helplessness paradigm in rats.
Journal: European journal of pharmacology 20011214
Title: Further characterisation of potential antidepressant action of flibanserin.
Journal: Psychopharmacology 20011201
Title: Lack of interaction between flibanserin and antidepressants in inducing serotonergic syndrome in rats.
Journal: The international journal of neuropsychopharmacology 20010301
Title: Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
Journal: Pharmacological research 20010201
Title: Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant.
Journal: European journal of pharmacology 19971211
